overall mortality rate after one year of follow-up was 28.7% or 58 deaths, among which 11 (5.45%) occurred during hospitalization. Fractures were more prevalent among women (71.3%) and rare among blacks (5%). Among the comorbidities, dementia and depression showed a statistically significant reduction in survival (p = 0.018 and 0.007, respectively). Conclusion: The mortality rate after one year of follow-up was 28.7%. Dementia and depression increased this rate.
Keywords
AbSTRACTObjective: To evaluate the mortality rate after one year and correlated preoperative factors, among patients with hip fractures. Methods: We prospectively studied 202 out of a total of 376 patients with a diagnosis of hip fracture who were
Objective: To evaluate the mortality rate after one year and correlated preoperative factors, among patients with hip fractures. Methods: We prospectively studied 202 out of a total of 376 patients with a diagnosis of hip fracture who were admitted to the Hospital Cristo Redentor, between October 2007 and March 2009. The database with the epidemiological analysis was set up during their hospitalization, and follow–up data were obtained preferentially by phone. Results: The overall mortality rate after one year of follow-up was 28.7% or 58 deaths, among which 11 (5.45%) occurred during hospitalization. Fractures were more prevalent among women (71.3%) and rare among blacks (5%). Among the comorbidities, dementia and depression showed a statistically significant reduction in survival (p = 0.018 and 0.007, respectively). Conclusion: The mortality rate after one year of follow-up was 28.7%. Dementia and depression increased this rate.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.